KHAJA MOHIUDDIN: Open Payments
NPI 1669931598 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 100 payments from 24 companies in 2025. Trend: 2023 $2,338 · 2024 $1,445 · 2025 $1,910
Food & beverage: $1,910
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $220 |
| Novo Nordisk Inc | 13 | $214 |
| ABBVIE INC. | 13 | $205 |
| AstraZeneca Pharmaceuticals LP | 10 | $198 |
| Sumitomo Pharma America, Inc. | 5 | $148 |
| PFIZER INC. | 8 | $147 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Lilly USA, LLC | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Astellas Pharma US Inc | 2 | $51 |
Products named: AIRSUPRA, OTEZLA, GEMTESA, VRAYLAR, ELIQUIS, LEQVIO, MOUNJARO, Rybelsus.
Industry payments across GA — which companies pay providers there.
